Revolution Medicines, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 11/13/2024 | 14.91 M | $676.23 M | 3.71% | 8.94% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 13.87 M | $628.86 M | 100.00% | 8.31% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 11.40 M | $517.05 M | -16.54% | 6.83% |
| FARALLON CAPITAL MANAGEMENT LLC | 11/14/2024 | 11.32 M | $513.26 M | 15.99% | 6.78% |
| BAKER BROS. ADVISORS LP | 11/14/2024 | 7.57 M | $343.26 M | 0.00% | 4.54% |
| NEXTECH INVEST LTD. | 11/14/2024 | 6.30 M | $285.56 M | 0.00% | 3.77% |
| JANUS HENDERSON GROUP PLC | 11/14/2024 | 6.14 M | $278.28 M | 32.26% | 3.68% |
| FMR LLC | 11/13/2024 | 5.88 M | $266.47 M | 4.44% | 3.52% |
| PARADIGM BIOCAPITAL ADVISORS LP | 11/14/2024 | 5.31 M | $240.99 M | 1.05% | 3.19% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 5.31 M | $240.96 M | 1.85% | 3.18% |
| STATE STREET CORP | 11/14/2024 | 5.28 M | $239.43 M | 4.11% | 3.16% |
| BELLEVUE GROUP AG | 11/14/2024 | 4.87 M | $220.92 M | -3.14% | 2.92% |
| BOXER CAPITAL, LLC | 11/14/2024 | 4.28 M | $194.07 M | 0.00% | 2.56% |
| ALPHABET INC. | 11/08/2024 | 4.26 M | $193.02 M | -19.80% | 2.55% |
| JPMORGAN CHASE & CO | 12/26/2024 | 4.14 M | $187.65 M | 32.81% | 2.48% |
| CASDIN CAPITAL, LLC | 11/14/2024 | 4.11 M | $186.58 M | -6.64% | 2.47% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 3.63 M | $164.52 M | 8.74% | 2.17% |
| BVF INC/IL | 11/14/2024 | 3.48 M | $157.76 M | -41.84% | 2.08% |
| WOODLINE PARTNERS LP | 11/14/2024 | 3.43 M | $155.72 M | 4.34% | 2.06% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11/14/2024 | 2.91 M | $132.09 M | -5.74% | 1.75% |
| AH CAPITAL MANAGEMENT, L.L.C. | 11/13/2024 | 2.75 M | $124.65 M | 0.00% | 1.65% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 2.35 M | $106.78 M | 62.60% | 1.41% |
| HOLOCENE ADVISORS, LP | 11/14/2024 | 2.15 M | $97.48 M | -2.45% | 1.29% |
| LORD, ABBETT & CO. LLC | 12/13/2024 | 1.83 M | $83.08 M | 100.00% | 1.10% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 1.76 M | $79.96 M | 58.88% | 1.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2024 | 1.65 M | $74.91 M | -30.11% | 0.99% |
| AMERIPRISE FINANCIAL INC | 11/14/2024 | 1.49 M | $67.36 M | 0.89% | 0.89% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 11/14/2024 | 1.33 M | $60.44 M | 45.82% | 0.80% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2024 | 1.20 M | $54.42 M | 0.00% | 0.72% |
| MARSHALL WACE, LLP | 11/14/2024 | 1.06 M | $48.30 M | 30.51% | 0.64% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2024 | 1.01 M | $45.80 M | 7.08% | 0.61% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/15/2024 | 997,455 | $45.23 M | 0.00% | 0.60% |
| AVIDITY PARTNERS MANAGEMENT LP | 11/14/2024 | 790,000 | $35.83 M | 4.64% | 0.47% |
| SIREN, L.L.C. | 11/13/2024 | 753,601 | $34.18 B | 100.00% | 0.45% |
| FINEPOINT CAPITAL LP | 11/13/2024 | 731,960 | $33.19 M | 0.34% | 0.44% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 704,584 | $31.95 M | -17.71% | 0.42% |
| MORGAN STANLEY | 11/14/2024 | 652,818 | $29.61 M | -34.42% | 0.39% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 577,408 | $26.19 M | 11.19% | 0.35% |
| CANDRIAM S.C.A. | 11/13/2024 | 563,782 | $25.57 M | 1.70% | 0.34% |
| FRED ALGER MANAGEMENT, LLC | 11/14/2024 | 540,673 | $24.52 M | 2,384.25% | 0.32% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 532,310 | $24.14 M | -17.50% | 0.32% |
| EVENTIDE ASSET MANAGEMENT, LLC | 11/14/2024 | 523,051 | $23.72 M | -19.63% | 0.31% |
| DAFNA CAPITAL MANAGEMENT LLC | 11/14/2024 | 517,994 | $23.49 M | 1.19% | 0.31% |
| MIC CAPITAL MANAGEMENT UK LLP | 11/14/2024 | 508,569 | $23.06 M | 0.00% | 0.30% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 459,337 | $20.83 M | 0.92% | 0.28% |
| VICTORY CAPITAL MANAGEMENT INC | 11/05/2024 | 437,750 | $19.85 M | -19.32% | 0.26% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 428,118 | $19.42 M | 6.88% | 0.26% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 394,473 | $17.89 M | 1.00% | 0.24% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 11/14/2024 | 350,000 | $15.87 M | 7.69% | 0.21% |
| MASS GENERAL BRIGHAM, INC | 10/16/2024 | 338,191 | $15.34 M | 0.00% | 0.20% |
Revolution Medicines, Inc.institutional Ownership - FAQ's
During the previous two years, 282 institutional investors and hedge funds held shares of Revolution Medicines, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 14.91 M
BlackRock Funding, Inc. /DE: 13.87 M
WELLINGTON MANAGEMENT GROUP LLP: 11.4 M
FARALLON CAPITAL MANAGEMENT LLC: 11.32 M
BAKER BROS. ADVISORS LP: 7.57 M
Nextech Invest Ltd.: 6.3 M
101.23% of Revolution Medicines, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 191.88 M shares in the last 24 months. This purchase volume represents approximately $8.47 B in transactions.